Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RULING ON FDA/LAERDAL INJUNCTION DISPUTE EXPECTED BY END OF APRIL

This article was originally published in The Gray Sheet

Executive Summary

RULING ON FDA/LAERDAL INJUNCTION DISPUTE EXPECTED BY END OF APRIL at the earliest from Judge Helen Frye at the U.S. District Court in Portland, Oregon. The court heard oral arguments in mid- February on the case, in which Laerdal is contesting agency efforts to enjoin the company from production and distribution of external defibrillators. Memoranda of fact and law based on the February hearing are due March 29, with responses to be completed by April 12.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002085

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel